Joint Project Team. 3.1.1 For the duration of the Research Term the Parties shall establish a Joint Project Team (the “JPT”) which shall be comprised of not less than two (2) nor more than four (4) research managers from each Party performing activities under the Research Plan. A Party may from time to time change its designee(s) on the JPT and/or designate a substitute employee to temporarily attend and perform the functions of such Party’s designee at any meeting of the JPT. 3.1.2 Each Party shall nominate one (1) Project Leader among the members of the JPT who will be responsible for coordinating the day-to-day work and communication between the Parties (the “Project Leaders”). 3.1.3 The JPT shall oversee the day-to-day activities under the Research Plan and shall discuss and propose any variations of or modifications or amendments to the Research Plan to the JRC. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. 3.1.4 During the Research Term the JPT shall meet at least once per month, by any means they deem appropriate.
Appears in 3 contracts
Sources: Research Collaboration and License Agreement, Research Collaboration and License Agreement (Protagonist Therapeutics, Inc), Research Collaboration and License Agreement (Protagonist Therapeutics, Inc)